Ann Thorac Med 2017 Jul-Sep;12(3):204-208
Department of Chest, Faculty of Medicine, Assiut University Hospital, Assuit, Egypt.
Download full-text PDF
Medicine (Baltimore) 2016 Aug;95(33):e4541
aDepartment of Endocrinology and Metabolic, Liaoning Provincial Corps Hospital of Chinese People's Armed Police Forces bDepartment of Endocrinology and Metabolic, Liaoning Provincial Corps Hospital of Chinese People's Armed Police Forces, Shenyang cDepartment of Endocrinology and Metabolic, Shenyang the Fourth Hospital of People, Shenyang, Liaoning, China.
Background: To observe the effect of alogliptin combined with metformin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy (500 mg, bid po, for at least 3 months), and evaluate its efficacy and safety.
Methods: After a 2-week screening period, adult patients (aged 36-72 years) entered a 4-week run-in/stabilization period. Then, patients were randomly assigned to either the intervention group (n = 55) or the control group (n = 50) for 26 weeks. Read More
Chest 2000 Dec;118(6):1661-70
Department of Respiratory Medicine, Glasgow Royal Infirmary, Glasgow, Scotland, UK.
Study Objectives: Although impairment of the diffusing capacity of the lung for carbon monoxide (DLCO) in heart transplant recipients is well-documented, there are limited data on its impact on exercise capacity in these patients. The aim of this study was to determine the effect of DLCO reduction on exercise capacity in heart transplant recipients.
Design: Descriptive cohort study. Read More
Patient Prefer Adherence 2015 18;9:1179-88. Epub 2015 Aug 18.
2nd Pulmonary Department, Sotiria Chest Diseases Hospital, Athens, Greece.
Introduction: Pulmonary function tests (PFTs) do not always predict functional limitations during exercise in sarcoidosis. Cardiopulmonary exercise testing (CPET) may facilitate the recognition of exercise intolerance in these patients.
Aim: As relevant data in sarcoid patients are limited, the aim of the study reported here was to assess exercise capacity impairment during a maximal CPET and to evaluate potential correlations with PFT measurements and radiological stages of the disease. Read More
Chest 1996 Jan;109(1):131-7
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA.
Purpose: To assess quantitative high-resolution CT (quantitative CT) as a diagnostic and prognostic tool in pulmonary lymphangioleiomyomatosis.
Methods: Spirometry, lung volumes, diffusing capacity, exercise physiology, and expiratory high-resolution CT (HRCT) examinations were performed on a cohort of ten patients with the diagnosis of lymphangioleiomyomatosis (LAM) referred to a tertiary care center. HRCT examinations were also done on ten normal control subjects. Read More